Skip to main navigation Skip to search Skip to main content

EBNA1-specific luminescent small molecules for the imaging and inhibition of latent EBV-infected tumor cells

    Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

    Abstract

    An EBNA1-specific small molecule (JLP2) has been synthesised. As a strong binder and dimerization inhibitor of EBNA1 in vitro, JLP2 may be used as a selective luminescent agent for the imaging and inhibition of latent EBV-infected cancer cells. This journal is © the Partner Organisations 2014.
    Original languageEnglish
    Pages (from-to)6517-6519
    JournalChemical Communications
    Volume50
    Issue number49
    DOIs
    Publication statusPublished - 21 Jun 2014

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'EBNA1-specific luminescent small molecules for the imaging and inhibition of latent EBV-infected tumor cells'. Together they form a unique fingerprint.

    Cite this